Cargando…
Hypoxia-inducible CAR expression: An answer to the on-target/off-tumor dilemma?
On-target/off-tumor toxicity is one of the major concerns regarding CAR T-cell therapy. Kosti et al.(1) demonstrate that this form of toxicity can be prevented by designing a CAR whose expression is controlled by oxygen levels in the tumor environment.
Autores principales: | Prinzing, Brooke, Krenciute, Giedre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080122/ https://www.ncbi.nlm.nih.gov/pubmed/33948575 http://dx.doi.org/10.1016/j.xcrm.2021.100244 |
Ejemplares similares
-
Steering CAR T cell epigenetic programs by tweaking manufacturing protocol
por: Dukes, Meghan W., et al.
Publicado: (2023) -
Answer to the Hamlet-like dilemma of lipid metabolites causing senile macular degeneration
por: Lo Faro, Valeria
Publicado: (2023) -
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
por: Yi, Zhongzhen, et al.
Publicado: (2018) -
COVID-19 and the differential dilemma
por: Climer, Sharlee
Publicado: (2021) -
MyD88/CD40 signaling retains CAR T cells in a less differentiated state
por: Prinzing, Brooke, et al.
Publicado: (2020)